The beta-glucuronidase intracisternal A particle insertion model results in similar overall MPSVII phenotype as the single base deletion model when on the same C57BL/6J mouse background

• Main Authors: Sean C. Devanney, Joseph M. Gibney, Colleen G. Le Prell, Thomas J. Wronski, J.I. Aguirre, Issam Mcdoom, Coy D. Heldermon
• Format: Article
• Language: English
• Published: Elsevier 2021-06-01
• Series: Molecular Genetics and Metabolism Reports
• Subjects: Mouse; Mucopolysaccharidosis VII; Sly syndrome (MPS VII); Survival; Bone; Retina
• Online Access: http://www.sciencedirect.com/science/article/pii/S2214426921000215

Two unique gene mutations in the enzyme beta-glucuronidase (GUSB) that result in the lysosomal storage disease Mucopolysaccharidosis (MPS) type VII had previously been reported to have differing disease phenotype severities when compared on differing mouse strains. The MPSVII mouse has proven to be a highly efficacious model to study mucopolysaccharidoses and for evaluating potential gene or stem cell therapies for lysosomal storage diseases. We examined the single base pair deletion (MPSVII) and the intracisternal A particle element insertion (MPSVII2J) in GUSB compared with control animals by skeletal measures, electroretinography, auditory-evoked brainstem response and life span on a C57BL/6J background strain. In all measures, both mutations result in either a trend toward or significant changes from the background strain control. In all measures, there is no significant phenotypic difference between the two mutations. The 2J variant is a more easily genotyped and equally affected phenotype, which holds promise for further studies of chimerism and stem cell therapy approaches.